Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06276829
Status:
COMPLETED
Last Update Posted:
2024-02-26
First Post:
2024-02-18
Brief Title:
Behçet and LDHAlbumin
Sponsor:
Ataturk University
Organization:
Ataturk University
Study Overview
Official Title:
A Convenient Parameter for Predicting Behçets Disease Severity Lactate DehydrogenaseAlbumin Ratio
Status:
COMPLETED
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
ABSTRACT Objective To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçets disease an inflammatory disease by comparing it to healthy controls
Patients and Methods In this retrospective cohort study patients with Behçets disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled LDH albumin levels and LDHalbumin ratio of both groups were compared Clinical findings and characteristics of Behçets patients and disease severity were recorded and analyzed in relation to LDHalbumin ratio
Patients and Methods In this retrospective cohort study patients with Behçets disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled LDH albumin levels and LDHalbumin ratio of both groups were compared Clinical findings and characteristics of Behçets patients and disease severity were recorded and analyzed in relation to LDHalbumin ratio
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None